TECX
HealthcareTectonic Therapeutic, Inc.
$19.71
$-1.20 (-5.74%)
Jan 5, 2026
Price History (1Y)
Analysis
Tectonic Therapeutic, Inc. is a biotechnology company in the healthcare sector with 51 employees. As of the available data, its market capitalization stands at $368.90 million. The financial health of Tectonic Therapeutic, Inc. reveals significant losses. Net income (TTM) amounts to -$67,298,000, while EBITDA is -$74,961,000. Free cash flow also shows a substantial deficit at -$46,341,000. Gross margin, operating margin, and profit margin are all at 0.0%. Returns on equity (-32.2%) and assets (-21.5%) indicate significant losses. The company's balance sheet is characterized by a low debt level of $1.24 million, but its current ratio is notably high at 29.15. Tectonic Therapeutic, Inc.'s valuation metrics paint a picture of a company with potentially low earnings potential. A forward P/E ratio of -4.21 suggests that investors are anticipating significant improvements in profitability. The price to book ratio is at 1.38, and the EV/EBITDA stands at -1.66.
This analysis is AI-generated for informational purposes only and should not be considered financial advice. Data may be delayed or inaccurate. Always do your own research and consult a qualified financial advisor before making investment decisions.
About Tectonic Therapeutic, Inc.
Tectonic Therapeutic, Inc., a biotechnology company, focuses on the discovery and development of therapeutic proteins and antibodies to modulate the activity of G protein-coupled receptors (GPCRs). It develops GEODe technology platform to enable the discovery and development of GPCR-targeted biologic medicines. The company's lead product is TX45, a Fc-relaxin fusion molecule that activates the RXFP1 receptor, the GPCR target of the hormone, and relaxin. It is also developing TX2100 for the treatment of hereditary hemorrhagic telangiectasia; GPCR modulator bispecific for treating fibrosis; and other GPCR modulators. The company is headquartered in Watertown, Massachusetts.
Visit website →Key Statistics
- Market Cap
- $368.90M
- P/E Ratio
- N/A
- 52-Week High
- $61.07
- 52-Week Low
- $13.70
- Avg Volume
- 472.75K
Company Info
- Industry
- Biotechnology
- Exchange
- NGM
- Country
- United States
- Employees
- 51